Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2022 Dec 13;13:1108216. doi: 10.3389/fimmu.2022.1108216

Corrigendum: Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects

Yanjing Huang 1, Mengdi Zhu 1, Zhuo Liu 1, Runan Hu 1, Fan Li 1, Yufan Song 1, Yuli Geng 1, Wenwen Ma 2, Kunkun Song 2,*, Mingmin Zhang 2,*
PMCID: PMC9793796  PMID: 36582229

In the published article, there was an error in the Funding statement. It was incorrectly stated that “This work was supported by the National Natural Science Foundation of China, No. 8190141809” instead of “This work was supported by the National Natural Science Foundation of China, No. 81904008.” The correct Funding statement appears below.

Funding

This work was supported by the National Natural Science Foundation of China, No. 81904008.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES